Further to our communication dated 3rd November 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 3rd November 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link https://ajantapharma.com//images/EarningsCallTranscriptQ2FY23.pdf .
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 3rd November 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EC-AudioQ2(Jul-Sep)2022-23.mp3
Further to our communication dated 29th July 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed written transcript of the earnings call held on 28th July 2022 at 5.00 p.m. Further, written transcript has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ1(Apr-Jun)2022-23.pdf This is for your information and records please.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 28th July 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallAudioQ1(Apr-Jun)2022-23.mp3 Written transcript of the same will be submitted in due course. This is for your information and records please.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 10th May 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link http://www.ajantapharma.com/AdminData/Results/EarningsC allTranscriptQ4(Jan-Mar)2021-22.pdf
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 10th May 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link in the attachment. Written transcript of the same will be submitted in due course. This is for your information and records please.
Further to our communication dated 31st January 2022 on earnings call, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, written transcript of the earnings call held on 31st January 2022 at 5.00 p.m. has been uploaded on the Company's website and can be accessed through the link: http://www.ajantapharma.com/AdminData/Results/EarningsCallTranscriptQ3(Oct-Dec)2021-22.pdf This is for your information and records please.
